AGNG


Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 05/12/21

Key Facts

Ticker AGNG
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $40,698,131
Net Asset Value (NAV) $28.07
Shares Outstanding 1,450,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.53%
Distribution Frequency Semi-Annually

Fund Prices As of 05/12/21

NAV $28.07 Daily Change -$0.34 -1.20%
Market Price $28.03 Daily Change -$0.42 -1.47%
30-Day Median Bid-Ask Spread 0.31%

Performance History

As of recent
(03/31/21)
As of recent
(03/31/21)
Fund NAV Market Price Index
1 Year 37.23% 37.70% 37.64%
3 Years 12.81% 12.79% 13.07%
Since Inception 13.85% 14.40% 14.16%
1 Year 28.96% 29.18% 29.36%
3 Years 15.04% 14.95% 15.31%
Since Inception 14.66% 15.15% 14.98%
Year-to-Date -1.25% -0.61% -1.22%
1 Month -0.36% -0.22% -0.37%
3 Months -1.25% -0.61% -1.22%
Since Inception 88.63% 93.16% 91.25%
Year-to-Date 3.39% 3.80% 3.48%
1 Month 4.70% 4.43% 4.76%
3 Months 3.06% 2.77% 3.12%
Since Inception 97.49% 101.72% 100.35%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 05/11/21

Return on Equity 14.40%
Weighted Avg. Market Cap 78,705 M
2020 2021
Price-to-earnings 32.98 29.06
Price-to-book value 4.39 4.02

Source: AltaVista Research, LLC

Fund Risk Stats As of 05/11/21

Versus Beta
S&P 500 0.83
MSCI EAFE 0.78
MSCI Emg. Mkts 0.63
Standard Deviation 18.30%

Source: AltaVista Research, LLC

Sector Breakdown As of 04/30/21

% of Net Assets
Health Care 93.4
Real Estate 5.2
Information Technology 0.7
Communication Services 0.4
Industrials 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/21

% of Net Assets
United States 57.3
Switzerland 7.5
Japan 6.6
Denmark 5.9
Britain 5.7
China 5.6
Ireland 3.4
South Korea 1.9
Germany 1.4
Belgium 1.3
France 0.8
Other/Cash 2.6

Source: AltaVista Research, LLC

Top Holdings As of 05/12/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.41 NOVOB DC NOVO NORDISK A/S-B BHC8X90 77.76 17,849 1,387,994.68
3.35 AZN ASTRAZENECA PLC-SPONS ADR 2989044 54.50 24,979 1,361,355.50
3.29 ABBV ABBVIE INC B92SR70 114.96 11,654 1,339,743.84
3.24 BSX BOSTON SCIENTIFIC CORP 2113434 41.35 31,930 1,320,305.50
3.23 REGN REGENERON PHARMACEUTICALS 2730190 507.14 2,595 1,316,028.30
3.20 LLY ELI LILLY & CO 2516152 192.35 6,771 1,302,401.85
3.17 BMY BRISTOL-MYERS SQUIBB CO 2126335 64.53 19,970 1,288,664.10
3.16 EW EDWARDS LIFESCIENCES CORP 2567116 87.47 14,690 1,284,934.30
3.14 JNJ JOHNSON & JOHNSON 2475833 168.20 7,588 1,276,301.60
3.10 MDT MEDTRONIC PLC BTN1Y11 123.12 10,248 1,261,733.76
3.09 AMGN AMGEN INC 2023607 250.83 5,008 1,256,156.64
3.09 RO SW ROCHE HOLDING AG-BR 7108918 354.29 3,545 1,255,971.83
2.98 SYK STRYKER CORP 2853688 244.76 4,948 1,211,072.48
2.77 4519 JP CHUGAI PHARMA CO 6196408 36.45 30,931 1,127,514.49
2.48 BIIB BIOGEN INC 2455965 274.02 3,682 1,008,941.64
2.03 ZBH ZIMMER BIOMET HO 2783815 163.77 5,038 825,073.26
1.99 ALC SW ALCON INC BJT1GR5 67.03 12,084 809,987.65
1.92 DXCM DEXCOM INC B0796X4 333.48 2,338 779,676.24
1.91 068270 KS CELLTRION INC B0C5YV1 233.41 3,329 777,008.40
1.76 WELL WELLTOWER INC BYVYHH4 71.04 10,103 717,717.12
1.71 BGNE BEIGENE LTD-ADR BYYWPW6 312.65 2,222 694,708.30
1.69 4503 JP ASTELLAS PHARMA INC 6985383 15.21 45,100 685,932.34
1.67 4543 JP TERUMO CORP 6885074 36.82 18,447 679,186.92
1.56 SGEN SEAGEN INC BLPK4D2 144.77 4,395 636,264.15
1.39 GMAB DC GENMAB A/S 4595739 362.30 1,561 565,557.67
1.39 FME GR FRESENIUS MEDICA 5129074 79.41 7,110 564,616.89
1.36 STMN SW STRAUMANN HOLDING AG-REG 7156832 1,461.74 379 553,998.46
1.35 3692 HK HANSOH PHARMACEU BJYKB72 3.90 141,000 549,217.43
1.17 VTR VENTAS INC 2927925 52.18 9,102 474,942.36
1.09 SN/ LN SMITH & NEPHEW PLC 0922320 21.27 20,839 443,148.59
1.08 NVCR NOVOCURE LTD BYSS4X4 179.83 2,437 438,245.71
1.08 TFX TELEFLEX INC 2881407 385.62 1,136 438,064.32
1.06 SOON SW SONOVA HOLDING AG-REG 7156036 280.46 1,538 431,354.13
1.06 UCB BB UCB SA 5596991 93.49 4,613 431,279.76
1.06 INCY INCYTE CORP 2471950 82.37 5,214 429,477.18
0.95 EXAS EXACT SCIENCES CORP 2719951 96.11 4,024 386,746.64
0.87 PODD INSULET CORP B1XGNW4 225.52 1,572 354,517.44
0.80 DVA DAVITA INC 2898087 122.78 2,634 323,402.52
0.78 853 HK MICROPORT SCIENTIFIC CORP B676TW7 7.41 43,000 318,649.76
0.72 ABMD ABIOMED INC 2003698 272.25 1,072 291,852.00
0.68 DEMANT DC DEMANT A/S BZ01RF1 48.51 5,721 277,511.89
0.64 GN DC GN STORE NORD A/S 4501093 77.15 3,382 260,935.43
0.63 COH AU COCHLEAR LTD 6211798 165.03 1,555 256,618.32
0.53 AMP IM AMPLIFON SPA B14NJ71 40.35 5,379 217,020.36
0.51 UTHR UNITED THERAPEUTICS CORP 2430412 195.49 1,051 205,459.99
0.50 NBIX NEUROCRINE BIOSC 2623911 92.15 2,217 204,296.55
0.50 AMED AMEDISYS INC 2024332 260.00 780 202,800.00
0.47 ORP FP ORPEA 7339451 125.17 1,524 190,755.35
0.47 OHI OMEGA HEALTHCARE 2043274 34.86 5,467 190,579.62
0.45 EXEL EXELIXIS INC 2576941 25.16 7,348 184,875.68
0.36 1858 HK BEIJING CHUNLI-H BVVPXP6 3.01 48,500 146,136.07
0.36 DNLI DENALI THERAPEUTICS INC BD2B4V0 51.17 2,846 145,629.82
0.36 INGN INOGEN INC BJSVLL5 63.18 2,293 144,871.74
0.36 HALO HALOZYME THERAPEUTICS INC 2975098 42.48 3,401 144,474.48
0.35 LHCG LHC GROUP INC B06DT50 190.32 750 142,740.00
0.33 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.55 244,000 135,415.04
0.33 FGEN FIBROGEN INC BSDRYR8 21.13 6,381 134,830.53
0.33 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.50 88,000 132,123.80
0.32 8086 JP NIPRO CORP 6641599 12.06 10,914 131,616.60
0.32 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.61 213,147 130,368.49
0.32 CSH-U CN CHARTWELL RETIRE B8S8C94 10.47 12,263 128,353.17
0.31 ACAD ACADIA PHARMACEU 2713317 21.83 5,804 126,701.32
0.31 RDUS RADIUS HEALTH INC BM68KK1 20.89 6,034 126,050.26
0.31 RYM NZ RYMAN HEALTHCARE LTD 6161525 10.73 11,717 125,692.72
0.31 LIVN LIVANOVA PLC BYMT0J1 83.47 1,501 125,288.47
0.31 BPMC BLUEPRINT MEDICINES CORP BWY52P3 91.65 1,359 124,552.35
0.31 BLUE BLUEBIRD BIO INC BBFL7S1 29.85 4,158 124,116.30
0.30 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 54.32 2,269 123,252.08
0.30 KORI FP KORIAN B1HKRM0 38.86 3,171 123,226.68
0.30 AED BB AEDIFICA B1G5XP1 122.81 1,003 123,181.18
0.30 EPZM EPIZYME INC B9Z1QZ7 8.55 14,243 121,777.65
0.30 OMER OMEROS CORP B4NB858 17.85 6,779 121,005.15
0.30 HRTX HERON THERAPEUTICS INC BJ0XLZ3 17.41 6,950 120,999.50
0.30 TCMD TACTILE SYSTEMS BZB1XF2 52.11 2,316 120,686.76
0.30 2500 HK VENUS MEDTECH -H BL6V047 8.55 14,100 120,555.49
0.30 BKD BROOKDALE SR B0PZN33 6.99 17,242 120,521.58
0.29 NUVA NUVASIVE INC B00GJC2 67.40 1,778 119,837.20
0.29 MMSI MERIT MEDICAL SYSTEMS INC 2580555 59.10 2,005 118,495.50
0.29 ITGR INTEGER HOLDINGS CORP BD06LM7 89.73 1,319 118,353.87
0.29 EKTAB SS ELEKTA AB-B SHS B0M42T2 13.38 8,761 117,241.12
0.29 SILK SILK ROAD MEDICAL INC BGHVXJ7 48.27 2,412 116,427.24
0.28 NHC NATIONAL HEALTHCARE CORP 2139731 70.51 1,585 111,758.35
0.27 MNKD MANNKIND CORP BF081J4 4.02 27,770 111,635.40
0.27 ANGO ANGIODYNAMICS INC B00CR04 22.39 4,964 111,143.96
0.27 AERI AERIE PHARMACEUTICALS INC BFRTDG1 17.59 6,318 111,133.62
0.27 ARNA ARENA PHARMACEUTICALS INC BF3N4P3 61.23 1,805 110,520.15
0.27 SBRA SABRA HEALTH CAR B5NLBP6 16.94 6,488 109,906.72
0.27 4547 JP KISSEI PHARM CO 6494061 19.12 5,640 107,823.91
0.26 LTC LTC PROPERTIES INC 2498788 39.10 2,750 107,525.00
0.26 GKOS GLAUKOS CORP BYMWL19 75.76 1,414 107,124.64
0.26 ENSG ENSIGN GROUP INC/THE B1YWPP8 81.75 1,296 105,948.00
0.26 NHI NATL HEALTH INVESTORS INC 2626125 65.65 1,608 105,565.20
0.26 TBPH THERAVANCE BIOPHARMA INC BMNDK09 18.87 5,510 103,973.70
0.25 PHM SM PHARMA MAR SA BMW2GT8 99.22 1,037 102,887.27
0.25 ALEC ALECTOR INC BJ4LDC4 16.79 6,105 102,502.95
0.23 ATEC ALPHATEC HOLDINGS INC BD60BG7 13.75 6,902 94,902.50
0.22 PNTG PENNANT GROUP INC/THE BKTC976 32.96 2,727 89,881.92
0.22 DHC DIVERSIFIED HEAL BKRN595 3.56 24,906 88,665.36
0.21 AMRN AMARIN CORP PLC -ADR 2301938 4.35 19,927 86,682.45
0.21 CASH 1.02 81,723 83,428.79
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.